AI-based risk model for breast cancer screening

Researchers assess the performance of an artificial intelligence-based risk model for breast cancer screening in Europe.

Clearside shares jump as reformulated TKI drug passes mid-stage test in wet AMD

Clearside Biomedical reported positive results from a Phase 2b trial of its tyrosine kinase inhibitor in patients with wet age-related macular degeneration, bolstering its prospects

October 10, 2024

Dexcom’s over-the-counter nod sets stage for broader CGM use

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. The Food and Drug Administration cleared the

March 7, 2024

Fruit fly research solves human disease and fuels new cancer immunotherapy approach

Scientists have solved a cellular murder mystery nearly 25 years after the case went cold. Following a trail of evidence from fruit flies to mice

January 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.